aluates Reports

$ 0.0

Automative

Global Non-small Cell Lung Cancer Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-20I5941

Global Non small Cell Lung Cancer Drugs Market Insights Forecast to 2028

BUY CHAPTERS

Global Non-small Cell Lung Cancer Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-20I5941

Report

December 2024

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Bristol Myers Squibb Company

Eli Lilly and Company

F Hoffmann La Roche Ltd

Merck& Co. Inc

Non-small Cell Lung Cancer Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Non-small Cell Lung Cancer Drugs Market

Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.

Market Analysis and Insights: Global Non-small Cell Lung Cancer Drugs Market

The global Non-small Cell Lung Cancer Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Non-small Cell Lung Cancer Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Non-small Cell Lung Cancer Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-small Cell Lung Cancer Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-small Cell Lung Cancer Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Non-small Cell Lung Cancer Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Non-small Cell Lung Cancer Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Non-small Cell Lung Cancer Drugs Market Report

Report Metric	Details
Report Name	Non-small Cell Lung Cancer Drugs Market
CAGR	5%
Segment by Type	Biologics Small Molecule Targeted Therapy Chemotherapy Other
Segment by Application	Lung Adenocarcinoma Squamous Cell Lung Carcinoma Large-cell Lung Carcinoma
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Merck & Co., Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Non-small Cell Lung Cancer Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-small Cell Lung Cancer Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-small Cell Lung Cancer Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Non-small Cell Lung Cancer Drugs Market report?

Ans: The main players in the Non-small Cell Lung Cancer Drugs Market are AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Merck & Co., Inc.

What are the Application segmentation covered in the Non-small Cell Lung Cancer Drugs Market report?

Ans: The Applications covered in the Non-small Cell Lung Cancer Drugs Market report are Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, Large-cell Lung Carcinoma

What are the Type segmentation covered in the Non-small Cell Lung Cancer Drugs Market report?

Ans: The Types covered in the Non-small Cell Lung Cancer Drugs Market report are Biologics, Small Molecule Targeted Therapy, Chemotherapy, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Biologics

1.2.3 Small Molecule Targeted Therapy

1.2.4 Chemotherapy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Lung Adenocarcinoma

1.3.3 Squamous Cell Lung Carcinoma

1.3.4 Large-cell Lung Carcinoma

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-small Cell Lung Cancer Drugs Market Perspective (2019-2030)

2.2 Global Non-small Cell Lung Cancer Drugs Growth Trends by Region

2.2.1 Non-small Cell Lung Cancer Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-small Cell Lung Cancer Drugs Historic Market Size by Region (2019-2024)

2.2.3 Non-small Cell Lung Cancer Drugs Forecasted Market Size by Region (2025-2030)

2.3 Non-small Cell Lung Cancer Drugs Market Dynamics

2.3.1 Non-small Cell Lung Cancer Drugs Industry Trends

2.3.2 Non-small Cell Lung Cancer Drugs Market Drivers

2.3.3 Non-small Cell Lung Cancer Drugs Market Challenges

2.3.4 Non-small Cell Lung Cancer Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Non-small Cell Lung Cancer Drugs by Players

3.1.1 Global Non-small Cell Lung Cancer Drugs Revenue by Players (2019-2024)

3.1.2 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Non-small Cell Lung Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Non-small Cell Lung Cancer Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Non-small Cell Lung Cancer Drugs Market Concentration Ratio

3.4.1 Global Non-small Cell Lung Cancer Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-small Cell Lung Cancer Drugs Revenue in 2023

3.5 Global Key Players of Non-small Cell Lung Cancer Drugs Head office and Area Served

3.6 Global Key Players of Non-small Cell Lung Cancer Drugs, Product and Application

3.7 Global Key Players of Non-small Cell Lung Cancer Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-small Cell Lung Cancer Drugs Breakdown Data by Type

4.1 Global Non-small Cell Lung Cancer Drugs Historic Market Size by Type (2019-2024)

4.2 Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Type (2025-2030)

5 Non-small Cell Lung Cancer Drugs Breakdown Data by Application

5.1 Global Non-small Cell Lung Cancer Drugs Historic Market Size by Application (2019-2024)

5.2 Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-small Cell Lung Cancer Drugs Market Size (2019-2030)

6.2 North America Non-small Cell Lung Cancer Drugs Market Size by Type

6.2.1 North America Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024)

6.2.2 North America Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030)

6.2.3 North America Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

6.3 North America Non-small Cell Lung Cancer Drugs Market Size by Application

6.3.1 North America Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024)

6.3.2 North America Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030)

6.3.3 North America Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

6.4 North America Non-small Cell Lung Cancer Drugs Market Size by Country

6.4.1 North America Non-small Cell Lung Cancer Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024)

6.4.3 North America Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Non-small Cell Lung Cancer Drugs Market Size (2019-2030)

7.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Type

7.2.1 Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024)

7.2.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030)

7.2.3 Europe Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

7.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Application

7.3.1 Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024)

7.3.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030)

7.3.3 Europe Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

7.4 Europe Non-small Cell Lung Cancer Drugs Market Size by Country

7.4.1 Europe Non-small Cell Lung Cancer Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024)

7.4.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Non-small Cell Lung Cancer Drugs Market Size (2019-2030)

8.2 China Non-small Cell Lung Cancer Drugs Market Size by Type

8.2.1 China Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024)

8.2.2 China Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030)

8.2.3 China Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

8.3 China Non-small Cell Lung Cancer Drugs Market Size by Application

8.3.1 China Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024)

8.3.2 China Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030)

8.3.3 China Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Non-small Cell Lung Cancer Drugs Market Size (2019-2030)

9.2 Asia Non-small Cell Lung Cancer Drugs Market Size by Type

9.2.1 Asia Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024)

9.2.2 Asia Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030)

9.2.3 Asia Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

9.3 Asia Non-small Cell Lung Cancer Drugs Market Size by Application

9.3.1 Asia Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024)

9.3.2 Asia Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030)

9.3.3 Asia Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

9.4 Asia Non-small Cell Lung Cancer Drugs Market Size by Region

9.4.1 Asia Non-small Cell Lung Cancer Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Non-small Cell Lung Cancer Drugs Market Size by Region (2019-2024)

9.4.3 Asia Non-small Cell Lung Cancer Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Non-small Cell Lung Cancer Drugs Introduction

11.1.4 AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024)

11.1.5 AstraZeneca Recent Developments

11.2 Bristol-Myers Squibb Company

11.2.1 Bristol-Myers Squibb Company Company Details

11.2.2 Bristol-Myers Squibb Company Business Overview

11.2.3 Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Introduction

11.2.4 Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024)

11.2.5 Bristol-Myers Squibb Company Recent Developments

11.3 Eli Lilly and Company

11.3.1 Eli Lilly and Company Company Details

11.3.2 Eli Lilly and Company Business Overview

11.3.3 Eli Lilly and Company Non-small Cell Lung Cancer Drugs Introduction

11.3.4 Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024)

11.3.5 Eli Lilly and Company Recent Developments

11.4 F. Hoffmann-La Roche Ltd

11.4.1 F. Hoffmann-La Roche Ltd Company Details

11.4.2 F. Hoffmann-La Roche Ltd Business Overview

11.4.3 F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Introduction

11.4.4 F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024)

11.4.5 F. Hoffmann-La Roche Ltd Recent Developments

11.5 Merck & Co., Inc.

11.5.1 Merck & Co., Inc. Company Details

11.5.2 Merck & Co., Inc. Business Overview

11.5.3 Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Introduction

11.5.4 Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024)

11.5.5 Merck & Co., Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Bristol Myers Squibb Company

Eli Lilly and Company

F Hoffmann La Roche Ltd

Merck& Co. Inc

List of Tables

Table 1. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Biologics

Table 3. Key Players of Small Molecule Targeted Therapy

Table 4. Key Players of Chemotherapy

Table 5. Key Players of Other

Table 6. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Non-small Cell Lung Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Non-small Cell Lung Cancer Drugs Market Share by Region (2019-2024)

Table 10. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Non-small Cell Lung Cancer Drugs Market Share by Region (2025-2030)

Table 12. Non-small Cell Lung Cancer Drugs Market Trends

Table 13. Non-small Cell Lung Cancer Drugs Market Drivers

Table 14. Non-small Cell Lung Cancer Drugs Market Challenges

Table 15. Non-small Cell Lung Cancer Drugs Market Restraints

Table 16. Global Non-small Cell Lung Cancer Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Non-small Cell Lung Cancer Drugs Revenue Share by Players (2019-2024)

Table 18. Global Top Non-small Cell Lung Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-small Cell Lung Cancer Drugs as of 2023)

Table 19. Global Non-small Cell Lung Cancer Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Non-small Cell Lung Cancer Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Non-small Cell Lung Cancer Drugs, Headquarters and Area Served

Table 22. Global Key Players of Non-small Cell Lung Cancer Drugs, Product and Application

Table 23. Global Key Players of Non-small Cell Lung Cancer Drugs, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2019-2024)

Table 27. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2025-2030)

Table 29. Global Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Non-small Cell Lung Cancer Drugs Revenue Share by Application (2019-2024)

Table 31. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Non-small Cell Lung Cancer Drugs Revenue Share by Application (2025-2030)

Table 33. North America Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Non-small Cell Lung Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Non-small Cell Lung Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Non-small Cell Lung Cancer Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Non-small Cell Lung Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Non-small Cell Lung Cancer Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 65. AstraZeneca Company Details

Table 66. AstraZeneca Business Overview

Table 67. AstraZeneca Non-small Cell Lung Cancer Drugs Product

Table 68. AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)

Table 69. AstraZeneca Recent Developments

Table 70. Bristol-Myers Squibb Company Company Details

Table 71. Bristol-Myers Squibb Company Business Overview

Table 72. Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Product

Table 73. Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)

Table 74. Bristol-Myers Squibb Company Recent Developments

Table 75. Eli Lilly and Company Company Details

Table 76. Eli Lilly and Company Business Overview

Table 77. Eli Lilly and Company Non-small Cell Lung Cancer Drugs Product

Table 78. Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)

Table 79. Eli Lilly and Company Recent Developments

Table 80. F. Hoffmann-La Roche Ltd Company Details

Table 81. F. Hoffmann-La Roche Ltd Business Overview

Table 82. F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Product

Table 83. F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)

Table 84. F. Hoffmann-La Roche Ltd Recent Developments

Table 85. Merck & Co., Inc. Company Details

Table 86. Merck & Co., Inc. Business Overview

Table 87. Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Product

Table 88. Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)

Table 89. Merck & Co., Inc. Recent Developments

Table 90. Research Programs/Design for This Report

Table 91. Key Data Information from Secondary Sources

Table 92. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Non-small Cell Lung Cancer Drugs Market Share by Type: 2023 VS 2030

Figure 3. Biologics Features

Figure 4. Small Molecule Targeted Therapy Features

Figure 5. Chemotherapy Features

Figure 6. Other Features

Figure 7. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Non-small Cell Lung Cancer Drugs Market Share by Application: 2023 VS 2030

Figure 9. Lung Adenocarcinoma Case Studies

Figure 10. Squamous Cell Lung Carcinoma Case Studies

Figure 11. Large-cell Lung Carcinoma Case Studies

Figure 12. Non-small Cell Lung Cancer Drugs Report Years Considered

Figure 13. Global Non-small Cell Lung Cancer Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Non-small Cell Lung Cancer Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Non-small Cell Lung Cancer Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global Non-small Cell Lung Cancer Drugs Market Share by Players in 2023

Figure 17. Global Top Non-small Cell Lung Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-small Cell Lung Cancer Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Non-small Cell Lung Cancer Drugs Revenue in 2023

Figure 19. North America Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

Figure 21. North America Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

Figure 22. North America Non-small Cell Lung Cancer Drugs Market Share by Country (2019-2030)

Figure 23. United States Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Non-small Cell Lung Cancer Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

Figure 27. Europe Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

Figure 28. Europe Non-small Cell Lung Cancer Drugs Market Share by Country (2019-2030)

Figure 29. Germany Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Non-small Cell Lung Cancer Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

Figure 37. China Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

Figure 38. Asia Non-small Cell Lung Cancer Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

Figure 40. Asia Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

Figure 41. Asia Non-small Cell Lung Cancer Drugs Market Share by Region (2019-2030)

Figure 42. Japan Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Non-small Cell Lung Cancer Drugs Market Share by Country (2019-2030)

Figure 52. Brazil Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. AstraZeneca Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)

Figure 59. Bristol-Myers Squibb Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)

Figure 60. Eli Lilly and Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)

Figure 61. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)

Figure 62. Merck & Co., Inc. Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-11W14373

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Hurthle Cell Carcinoma Treatment Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-35B1140

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Anaplastic Large Cell Lymphoma Drugs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-27H888

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Anaplastic Large Cell Lymphoma Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-16R5994

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Non-small Cell Lung Cancer Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-20I5941

Global Non-small Cell Lung Cancer Drugs Market Insights, Forecast to 2030

FEATURED COMPANIES

Non-small Cell Lung Cancer Drugs Market Size

Non-small Cell Lung Cancer Drugs Market

Scope of Non-small Cell Lung Cancer Drugs Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Non-small Cell Lung Cancer Drugs Market report?

What are the Application segmentation covered in the Non-small Cell Lung Cancer Drugs Market report?

What are the Type segmentation covered in the Non-small Cell Lung Cancer Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS